Drugs / AL003
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT03822208 Comparator | Mar 2019 → May 2021 | Alzheimer disease | Alector Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AL003 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03822208 ↗ |
| Route | Intravenous | “AL003 by intravenous (IV) infusion” NCT03822208 ↗ |